Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Therapy Name | ATRN-W1051 |
Synonyms | |
Therapy Description |
ATRN-W1051 is a WEE1 inhibitor, which potentially decreases tumor cell proliferation and tumor growth (Cancer Res (2023) 83 (7_Supplement): 6177) |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
ATRN-W1051 | ATRNW1051|ATRN W1051|APR-1051|APR1051|APR 1051 | WEE1 Inhibitor 7 | ATRN-W1051 is a WEE1 inhibitor, which potentially decreases tumor cell proliferation and tumor growth (Cancer Res (2023) 83 (7_Supplement): 6177) |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|---|---|---|---|---|---|
NCT06260514 | Phase I | ATRN-W1051 | Study of APR-1051 in Patients With Advanced Solid Tumors (ACESOT-1051) | Recruiting | USA | 0 |